Ceribell

Mountain View, United States Founded: 2014 • Age: 12 yrs Listed
Portable EEG devices for point-of-care seizure diagnosis are provided.

About Ceribell

Ceribell is a publicly listed company based in Mountain View (United States) founded in 2014 by Chris Chafe. Portable EEG devices for point-of-care seizure diagnosis are provided. It operates in the Healthcare and Technology sectors. Ceribell has raised $187.52 million across 4 funding rounds from investors including UCB, LivaNova and RA Capital. The company has 281 employees. Its website ceribell.com draws about 31 thousand monthly visits. Ceribell offers products and services including Point-of-Care EEG, Clarity EEG Portal, and EEG University. Its focus areas include High Tech, Brain Computer Interface, Applications and Diagnostics. Its competitors include Kernel, Mynd Analytics and BrainScope; 2 of its 3 listed competitors have raised funding.

Company details

Founded in 2014 and based in Mountain View, United States, Ceribell operates in the medical device sector with a focus on neurology diagnostics. Point-of-care EEG systems are developed for seizure detection, including a 10-channel EEG Headband for data recording and a pocket-sized EEG Recorder for real-time signal display, brain activity analysis, and monitoring alerts.

  • Headquarters Mountain View, United States
  • Employees 281
  • Founders Chris Chafe
  • Stage Public
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ceribell.com
  • Social LinkedIn X Instagram YouTube
  • Legal Name Ceribell, Inc.
Key Metrics
  • Annual Revenue
    $89.06 M (USD)
    36.09
    as on Dec 31, 2025
  • Net Profit
    -$53.41 M (USD)
    -32.03
    as on Dec 31, 2025
  • EBITDA
    -$57.06 M (USD)
    -47.95
    as on Dec 31, 2025
  • Total Equity Funding
    $187.52M (USD)

    in 4 rounds

  • Latest Funding Round
    $50M (USD), Series C

    Sep 2022

  • Investors
    UCB

    & 9 more

  • Employee Count
    281

Products & Services of Ceribell

Ceribell offers a comprehensive portfolio of products and services, including Point-of-Care EEG, Clarity EEG Portal, and EEG University.

Point-of-Care EEG
Medical Device

Device for rapid EEG monitoring in critical care settings

Clarity EEG Portal
Software Platform

Platform for EEG data management and seizure analysis

EEG University
Educational Service

Online resource for EEG training and guidelines

Apps and channels of Ceribell

its YouTube channel Ceribell has 516 subscribers and 30 videos.

Ceribell
YouTube 516 subscribers 30 videos Science & Technology
Open channel

Videos from Ceribell

The most watched videos on Ceribell's YouTube channel, Ceribell (516 subscribers). Click a video to play it here.

Ceribell AI-powered point-of-care EEG is revolutionizing seizure management in acute care
6.5K views
Ceribell with ClarityPro
716 views
Ceribell Fox Business News "AI Week" Highlight Reel
509 views
Ceribell Point-of-Care EEG with AI
446 views

More on Ceribell.

Funding Insights of Ceribell

Ceribell has successfully raised a total of $187.52M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $187.52M
  • Total Rounds 4
  • Last Round Series C β€” $50M
  • First Round $35M

    (Sep 2018)

  • Investors Count 10

All 4 funding rounds of Ceribell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2022$50MSeries C–Ally Bridge Group
–
Apr 2021$102.52MSeries C–Longitude Capital, The Rise Fund
May 2020$20MDebt – Venture––
Sep 2018$35MSeries B–Optima Capital, The Rise Fund
Valuation history

10 investors in total: 10 institutional.

Investors in Ceribell

Ceribell has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include UCB, LivaNova and RA Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity and hedge fund investments in healthcare are managed.
ally-bridge.comHong Kong, China
Private equity firm focused on life science sector
longitudecapital.comMenlo Park, United States
Sector-agnostic VC investment company investing globally
therisefund.comSan Francisco, United States
Red Tree Venture Capital is focused on life science investments.
redtreevc.comRedwood City, United States
Structured debt is provided to life sciences and technology firms.
2004horizontechfinance.comFarmington, United States
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
2004racap.comBoston, United States
Operates as an employee-owned hedge fund focused on long/short equity strategies.
2007redmilegroup.comSan Francisco, United States
optimacapital.pt
Therapeutic devices for cardiac and neurological conditions are provided worldwide.
2015livanova.comLondon, United Kingdom
Therapies for immunological and neurological disorders are developed.
1928ucb.comBrussels, Belgium
Premium access

Investor details for Ceribell

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ceribell

113 people are tracked at Ceribell (46 in leadership, 67 in team); the tracked headcount is 281.

NameRoleGroup
Chris Chafe
Co-FounderLeadership
Jessy Dorn
VP, Clinical AffairsLeadership
Baharan Kamousi
VP, Data ScienceLeadership
Michelle Hofmann
Associate Director Clinical OperationsLeadership
Kevin Kearney
VP, Account Management SalesLeadership
Kurt Kemling
Director Of Digital MarketingLeadership
Dave Foehr
VP, FinanceLeadership
Jane Chao
Co-Founder & CEOLeadership
Raymond Woo
CTOLeadership
Shaun Gambina
Director Of Revenue OperationsLeadership
Scott Blumberg
CFOLeadership
Trung Pham
Sr. Director, Manufacturing And Facilities OperationsLeadership
Pauline F.
Chief Of StaffLeadership
Asher Cohen
Executive Director Of Product & DesignLeadership
Michael Cellini
Regional Director, Account AcquistionLeadership
Kim McKeon
Head Of People And CultureLeadership
Loni Olazaba
Head Of Talent AcquisitionLeadership
Devon Fetterman
Head Of ContractsLeadership
Alyssa Hobson
Regional Account DirectorLeadership
Chad Meyers
Regional Business DirectorLeadership

93 more people are available in the full profile.

Premium access

Complete people profiles for Ceribell

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Ceribell

Ceribell is a publicly listed company on the NASDAQ with ticker symbol CBLL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date11 Oct 2024
  • Listed onNASDAQ: CBLL
  • Listed entityCeriBell, Inc.
  • Exchange sectorHealth technology
  • ISINUS15678C1027
  • Share price$26.14 (+3.48% on the day) · 2026-10-13
  • Market capitalisation$1.00B
  • EPS (diluted, trailing year)$-1.76
  • Volume (last session)542,698

Financials of Ceribell

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$89.1M-$53.4M-$57.1M
2024$65.4M-$40.5M-$38.6M
2023$45.2M-$29.5M-$29.2M
2022$25.9M-$37.2M-$35.5M
Premium access

Detailed financial statements for Ceribell

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Ceribell

4 dated milestones of Ceribell across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ceribell is founded.
  2. Funding First funding round of $35.0M.
  3. Funding Latest funding round, Series C, of $50.0M.
  4. IPO Lists on the stock exchange (IPO).

Competitors of Ceribell

Ceribell has 3 listed competitors in our database, 2 of them funded. They include Kernel, Mynd Analytics and BrainScope.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
kernel.com2016Los Angeles, United States$158.25M
Multimodal brain measurement technology is developed for neuromedicine applications.
myndanalytics.com1999Aliso Viejo, United States105
Provider of reference data and analytic tools for clinicians and researchers in psychiatry.
brainscope.com2006Bethesda, United States$62.15M38
Developer of AI-driven EEG platform transforming brain electrical activity into insights
Premium access

Detailed competitors of Ceribell

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ceribell

The website of Ceribell (ceribell.com) receives about 31.2K visits a month.

  • Monthly visits
    31.2K

    ▲ 4.9% vs previous month

Similar websites

Websites whose visitors overlap most with Ceribell. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ean.org
100%
82.7K#342,133View details
zeto-inc.com
73%
11.7K#2,104,157View details
epidiolex.com
73%
#1,010,128View details

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Ceribell (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ceribell

Premium access

Complete news archive for Ceribell

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ceribell

Ceribell was founded in 2014 and raised its 1st funding round 4 years after it was founded.

Ceribell is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

Ceribell is a funded company, having raised a total of $187.52M across 4 funding rounds to date. The company's 1st funding round was a Series B of $35M, raised on Sep 2018.

Ceribell has 281 employees.

Annual revenue of Ceribell is $89.06M as on Dec 31, 2025.

Founded in 2014 and based in Mountain View, United States, Ceribell operates in the medical device sector with a focus on neurology diagnostics. Point-of-care EEG systems are developed for seizure detection, including a 10-channel EEG Headband for data recording and a pocket-sized EEG Recorder for real-time signal display, brain activity analysis, and monitoring alerts.

Ceribell's top competitors include BrainScope, Mynd Analytics and Kernel.

Ceribell offers Point-of-Care EEG, Clarity EEG Portal, and EEG University.

Yes, Ceribell is publicly traded on NASDAQ under the ticker symbol CBLL.

Ceribell has 10 investors. Key investors include UCB, LivaNova, RA Capital, Horizon Tech Finance, and Ally Bridge Group.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available